Catherine Schairer

Staff Scientist
Division of Cancer Epidemiology & Genetics, Metabolic Epidem
National Cancer Institute
United States of America

Scientist Medical Sciences
Biography

Dr. Catherine Schairer joined DCEG as a health statistician in 1982. She has a Master of Science degree in biostatistics from the University of California, Los Angeles, and a Ph.D. in epidemiology from Johns Hopkins University, Baltimore, Maryland. Dr. Schairer has a long-standing interest in breast cancer research. She is a co-principal investigator of the Breast Cancer Detection Demonstration Project Follow-up study, and recently led a case-control study of inflammatory breast cancer in North Africa. Dr. Schairer has served as Chair of the NCI Special Studies Institutional Review Board since 2011

Research Intrest

Inflammatory breast cancer – etiology, trends in rates; Exogenous and endogenous hormones and breast cancer riskl; Study design and epidemiologic methods; Research ethics

List of Publications
Le L, Schairer C, Hablas A, Meza J, Watanabe-Galloway S, Ramadan M, Merajver SD, Seifeldin IA, Soliman AS. Reliability of medical records in diagnosing inflammatory breast cancer in Egypt. BMC research notes. 2017 Mar 16;10(1):126.
Campbell PT, Newton CC, Kitahara CM, Patel AV, Hartge P, Koshiol J, McGlynn KA, Adami HO, de González AB, Freeman LE, Bernstein L. Body Size Indicators and Risk of Gallbladder Cancer: Pooled Analysis of Individual-Level Data from 19 Prospective Cohort Studies. Cancer Epidemiology and Prevention Biomarkers. 2017 Mar 17.
Schairer C, Gadalla SM, Pfeiffer RM, Moore SC, Engels EA. Diabetes, abnormal glucose, dyslipidemia, hypertension and risk of inflammatory and other breast cancer. Cancer Epidemiology and Prevention Biomarkers. 2017 Jan 1:cebp-0647.

Global Scientific Words in Medical Sciences